Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Mosaad M. El Gammal"'
Autor:
Ahmed A. Zeeneldin, Hanan Ramadan, Mosaad M. El Gammal, Magdy M. Saber, Dina Elgamal, Mohamed A. Sherisher
Publikováno v:
Journal of the Egyptian National Cancer Institute, Vol 26, Iss 3, Pp 127-137 (2014)
Background and aims: To study the clinico-pathological features, treatments and outcomes of gastric carcinoma (GC) in the elderly (⩾65 years) and the non-elderly Egyptian patients. Methods: This retrospective cohort study included 168 patients with
Externí odkaz:
https://doaj.org/article/429a97e4511b448885b10fc180160fe6
Autor:
Magdy M. Saber, Ahmed A. Zeeneldin, Mosaad M. El Gammal, Salem E. Salem, Amira D. Darweesh, Alshaymaa A. Abdelaziz, Manar Monir
Publikováno v:
Journal of the Egyptian National Cancer Institute, Vol 26, Iss 2, Pp 103-108 (2014)
Introduction: Female germ cell tumors (GCTS) are rare tumors that carry a good prognosis. Aim: To report the experience of the Egyptian National Cancer Institute (ENCI) in managing female GCTs. Methods: This retrospective study included 19 females wi
Externí odkaz:
https://doaj.org/article/5ed70740293b49ae8a191747408e4e59
Autor:
Abdel-Hameed I. M. Ebid, Ahmed Hossam, Mosaad M. El Gammal, Sameh Soror, Nadia O.M Mangoud, Mohamed Adel Mahmoud
Publikováno v:
Journal of Chemotherapy. 34:381-390
High dose methotrexate (HDMTX) is an essential agent in chemotherapeutic regimens used in various hematological malignancies in Egyptian adults. The research for the impact of gene polymorphism on HDMTX induced toxicities and delayed elimination is a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f36d5dad9143cbb8e06774fe105a65da
https://doi.org/10.1080/1120009x.2021.2009723
https://doi.org/10.1080/1120009x.2021.2009723
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 20:459-467
Background Core binding factor acute myeloid leukemia (CBF-AML) encodes 2 recurrent cytogenetic abnormalities, t(8;21) and inv(16), which carries an overall good prognosis. However, some patients will develop a relapse. We sought define the unfavorab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::934c4aa7fcabda851851942585830fe7
https://doi.org/10.1016/j.clml.2020.02.002
https://doi.org/10.1016/j.clml.2020.02.002
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 20:156-167
Background Acute promyelocytic leukemia (APL) has a characteristic peculiar morphologic and genetic features as well as a more favorable outcome. We studied the differential effect of bcr-1 and bcr-3 isoforms of the promyelocytic leukemia/retinoic ac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b839763630bab7f9ba71e4e2f7598c13
https://doi.org/10.1016/j.clml.2019.08.006
https://doi.org/10.1016/j.clml.2019.08.006
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 19:e406-e413
Early blast clearance to induction chemotherapy in acute myeloid leukemia (AML) is an important prognostic indicator of treatment outcome in addition to genetics and molecular genetics. We evaluated the prognostic value of bone marrow aspiration (BMA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae24c4bacf1adf2272af8d954bf4060f
https://doi.org/10.1016/j.clml.2019.03.024
https://doi.org/10.1016/j.clml.2019.03.024
Autor:
Ayda K. Kelany, Omnia M. Abo-Elazm, Jerald P. Radich, Gamal T. A. Ebid, Youssef Madney, Mosaad M. El Gammal, Olga Sala Torra
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 19:e281-e290
Background Genotypic mutation of fms like tyrosine kinase 3 (FLT3), Nucleophosmin (NPM1), and DNA-methyltransferase 3A (DNMT3A) has been involved in the leukemogenesis of acute myeloid leukemia (AML), with the well known poor prognostic role of FLT3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9e86da2360fec53d9a3352ee686f24b
https://doi.org/10.1016/j.clml.2019.02.001
https://doi.org/10.1016/j.clml.2019.02.001
Autor:
Maha M. Eid, Amany H. Abdelrahman, Ola M. Eid, Mahmoud M. Kamel, Mosaad M. El Gammal, Mohamed T.H. Sallam, Hanaa R.M. Attia, Mona H. Ibrahim
Publikováno v:
Current pharmaceutical biotechnology. 21(13)
Background: Multiple Myeloma (MM) is a complex hematologic malignancy, driven by several genetic and epigenetic alterations. MiRNAs as biomarkers have become a rapidly growing research area in the last decade. Aim: The aim was to study the expression
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11753217379175a814987e14e312c988
https://pubmed.ncbi.nlm.nih.gov/32196445
https://pubmed.ncbi.nlm.nih.gov/32196445
Autor:
Mona S Abdellateif, Mosaad M. El Gammal, Mohamed Ahmed Abd El Salam, Samar Hassab‐Allah Kassem, Noha H Ibrahim
Publikováno v:
AndrologiaREFERENCES. 51(10)
Prostate cancer (PC) is considered as the fifth cause of cancer deaths worldwide. The exact etiopathogenesis is unclear; however, genetic predisposition, hormonal influencers, lifestyle and environmental factors act as major contributors. It has been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e48d3a1d1022741fe28420f02de77409
https://pubmed.ncbi.nlm.nih.gov/31483058
https://pubmed.ncbi.nlm.nih.gov/31483058
Autor:
Basma M. Elgamal, Naglaa M. Hassan, Lamiaa A. Fathalla, Mosaad M. El Gammal, Rasha Mahmoud Allam, Omnia K. ElGebaly
Publikováno v:
Indian Journal of Public Health Research & Development. 10:1519
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d3f4e40275fbc5395ac1519f556155c1
https://doi.org/10.37506/v10/i12/2019/ijphrd/192424
https://doi.org/10.37506/v10/i12/2019/ijphrd/192424